Yasukata Ohashi

664 total citations
25 papers, 540 citations indexed

About

Yasukata Ohashi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yasukata Ohashi has authored 25 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yasukata Ohashi's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Yasukata Ohashi is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Yasukata Ohashi collaborates with scholars based in Japan, South Korea and North Korea. Yasukata Ohashi's co-authors include Ikuo Saiki, Isaku Yoshioka, Kazuhiro Tsukada, Mitsuhiro Matsuo, Shigeaki Sawada, Keiichi Koizumi, Hiroaki Sakurai, T Taguchi, M Kurihara and S Matsuno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and British Journal of Cancer.

In The Last Decade

Yasukata Ohashi

21 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasukata Ohashi Japan 9 240 124 104 90 90 25 540
Azharuddin Sajid Syed Khaja Saudi Arabia 14 315 1.3× 294 2.4× 255 2.5× 43 0.5× 9 0.1× 42 729
Rong‐Hua Yin China 14 80 0.3× 360 2.9× 108 1.0× 71 0.8× 30 0.3× 36 571
Lijun Xu China 13 196 0.8× 156 1.3× 212 2.0× 34 0.4× 17 0.2× 36 505
Tümen Mansuroglu Germany 10 83 0.3× 145 1.2× 42 0.4× 75 0.8× 133 1.5× 14 395
Kaoru Murakami-Mori United States 14 273 1.1× 216 1.7× 196 1.9× 75 0.8× 15 0.2× 17 545
Sven Malchow United States 10 245 1.0× 117 0.9× 594 5.7× 53 0.6× 44 0.5× 11 870
Ping‐Fang Hu China 13 65 0.3× 217 1.8× 49 0.5× 93 1.0× 94 1.0× 20 410
Yanhong Liu China 14 95 0.4× 176 1.4× 116 1.1× 24 0.3× 9 0.1× 31 485
William Puszyk United States 15 92 0.4× 421 3.4× 63 0.6× 58 0.6× 65 0.7× 20 683

Countries citing papers authored by Yasukata Ohashi

Since Specialization
Citations

This map shows the geographic impact of Yasukata Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasukata Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasukata Ohashi more than expected).

Fields of papers citing papers by Yasukata Ohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasukata Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasukata Ohashi. The network helps show where Yasukata Ohashi may publish in the future.

Co-authorship network of co-authors of Yasukata Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasukata Ohashi. A scholar is included among the top collaborators of Yasukata Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasukata Ohashi. Yasukata Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ohashi, Yasukata, Junichi Masuda, Katsuji Teruya, et al.. (2023). Introducing Ritonavir-Boosted Nirmatrelvir (Paxlovid) at the National Center for Global Health and Medicine: Surveys Following its Introduction. Kansenshogaku zasshi. 97(4). 125–135.
3.
Tsuji, Daiki, Hiroshi Ishikawa, Rei Tanaka, et al.. (2023). Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer. European Journal of Clinical Pharmacology. 79(3). 407–414. 1 indexed citations
4.
Ohashi, Yasukata, Hironori Ueno, Takahiro Yano, et al.. (2021). Importance of Compliance With Guidelines for the Prevention of Varicella-Zoster Virus Reactivation in Multiple Myeloma. In Vivo. 35(6). 3289–3296. 4 indexed citations
5.
Ohashi, Yasukata, et al.. (2021). Contamination of lenalidomide on blister packages after administration and its exposure countermeasures. Current Problems in Cancer. 45(5). 100727–100727. 1 indexed citations
6.
7.
Ishikawa, Hiroshi, Daiki Tsuji, Yohei Kawasaki, et al.. (2019). Irinotecan and cisplatin therapy-induced neutropenia as a prognostic factor in patients with extensive-disease small cell lung cancer. Annals of Oncology. 30. ix27–ix27. 1 indexed citations
8.
9.
Kee, Ji‐Ye, Yoshihisa Arita, Yasukata Ohashi, et al.. (2012). Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo. Molecular and Clinical Oncology. 1(1). 35–40. 21 indexed citations
10.
11.
12.
Kato, Toshiaki, et al.. (2009). [Revision of the informed consent form for patients based on investigation of adverse events of mFOLFOX6 regimen].. PubMed. 36(10). 1697–702.
13.
Koizumi, Keiichi, Yasukata Ohashi, Yasushi Aozuka, et al.. (2007). CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncology Reports. 17(6). 1511–6. 37 indexed citations
14.
Lee, Soojin, Yasukata Ohashi, Hiroaki Sakurai, & Ikuo Saiki. (2003). TAC-101 inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma. Cancer Letters. 198(2). 169–177. 2 indexed citations
15.
Sawada, Shigeaki, Isaku Yoshioka, Yasukata Ohashi, et al.. (2003). Increased surgical stress promotes tumor metastasis. Surgery. 133(5). 547–555. 162 indexed citations
16.
Ohashi, Yasukata, et al.. (2003). Prevention of Intrahepatic Metastasis by Curcumin in an Orthotopic Implantation Model. Oncology. 65(3). 250–258. 60 indexed citations
17.
Fujiwara, Keiichi, Ichiro Kohno, Katsuaki Tanaka, et al.. (1999). Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group.. PubMed. 19(1B). 639–44. 7 indexed citations
18.
Sakata, Yasushi, S Matsuno, M Kurihara, et al.. (1999). Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. British Journal of Cancer. 80(3-4). 438–443. 69 indexed citations
19.
20.
Tsuda, Hiroyuki, Kiyoshi Takatsuki, R Ohno, et al.. (1994). Treatment of adult T-cell leukaemia–lymphoma with irinotecan hydrochloride (CPT-11). British Journal of Cancer. 70(4). 771–774. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Azharuddin Sajid Syed Khaja Breakdown of academic impact, for papers by Rong‐Hua Yin Breakdown of academic impact, for papers by Lijun Xu Breakdown of academic impact, for papers by Tümen Mansuroglu Breakdown of academic impact, for papers by Kaoru Murakami-Mori Breakdown of academic impact, for papers by Sven Malchow Breakdown of academic impact, for papers by Ping‐Fang Hu Breakdown of academic impact, for papers by Yanhong Liu Breakdown of academic impact, for papers by William Puszyk
Rankless by CCL
2026